FDA Investigator Nancy F Scheraga

Nancy F Scheraga has conducted inspections on 44 sites in 3 countries as of 25 Mar 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
44
Last Inspection Date:
25 Mar 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Spain, Denmark
FDA Investigators that have inspected at least one site in common with Nancy F Scheraga:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Allen Lou, Amir Alavi, Amy L Singer, Amy M Cramer, Amy N Chen, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Annemarie B Randow, Annemarie Bodnar, Anthony J Donato, Anthony M Criscuolo, Jr, Atul J Agrawal, Barbara J Maulfair, Barbara Jwilimczyk Macri, Byungja E Marciante, Cary Greene, Cassandra L Abellard, Charles J Chacko, Christina N Maurino, Christine M Cerenzio, Concepcion Cruz, Jr, Craig W Swanson, Cynthia Jim, CSO, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, David A Oluwo, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Devon Jenkins, Dhaval H Patel, Dinesh Kumar, Dorothy J Denes, Douglas C Kovacs, Edward O'shaughnessy, Edwin Melendez, Emest F Bizjak, Emily A Walters, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Frank J Marciniak, Frank Wackes, Frederick F Razzaghi, George Pyramides, German Rivera, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, James R Birkenstamm, Janet A Rajan, Javier E Santos, Jawaid Hamid, Jay T Wong, Jean M Kelahan, Jeffery B Medwid, PhD, Jenny Sung, Jessica S Estriplet, Jogy George, Jonathan S Helfgott, Jonee J Mearns, Jose Acruz Gonzalez, Jose M Cayuela, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Kazi Rafiquzzaman, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kerry A Kurdilla, Kevin Obrien, Ko U Min, Krishnaiah Yellela, Kristina L Conroy, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Larry K Austin, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, LCDR Wilfred A Darang, Li Li, Liatte Kreuger, PharmD, Linda J Eason, Loretta Nemchik, Luis A Dasta, Maotang Zhou, PhD, Marcelo O Mangalindan, Jr, Marcia D Fields, Maria Estrella, Maria Manzoni, PhD, Matthew A Spataro, Melba Trivera Clavell, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Meyer J Slobotsky, Michael R Klapal, Michael Serrano, Michele Gottshall, Miral B Patel, Monika Borkowska, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Niketa Patel, Nikki S Ramirez, Nina Yang, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul Mouris, Peter R Lenahan, Rachael A Moliver, Rachael O Oyewole, Regina T Brown, Richard W Thornton, Robert D Tollefsen, Robin P Mathew, Rose Ljean Mary, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Samir C Gala, Sandra A Boyd, Sarah Forney, Satheesh K Podaralla, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Sherri J Liu, Shirley S Wen, Sidney B Priesmeyer, Sinai I Davis, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Suchan Kim, Sunita Iyer, Susan M Joseph, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tanya R Syffrard, Tara G Bizjak, Tekalign Wondimu, Tonia F Bernard, Unnee Ranjan, Valerie C Reed, Victoria Spivak, William J Leonard, William R Chang, Xiaohan Cai, PhD, Youmin Wang, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhijin Chen

Nancy F Scheraga's Documents

Publish Date Document Type Title
January, 2019 FDA 483 Response Greenbrier International, Inc - Form 483R, 2019-02-05
September, 2018 FDA 483 Chr. Olesen Synthesis A/S - Form 483, 2018-09-14
April, 2018 FDA 483 Amneal Complex Products Research LLC - Form 483, 2018-04-18
April, 2019 FDA 483 ImprimisRx NJ - Form 483, 2019-04-09
May, 2018 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2018-05-30
March, 2019 EIR Accupac, LLC - EIR, 2019-04-08
July, 2017 FDA 483 DIAMOND DRUGS, INC. - Form 483, 2017-07-21
February, 2016 FDA 483 Response Elite Laboratories, Inc. - Form 483R, 2016-08-16
August, 2016 FDA 483 Town and Country Compounding and Consultation Services, LLC - Form 483, 2016-08-22
January, 2019 FDA 483 Greenbrier International, Inc - Form 483, 2019-01-18
March, 2018 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2018-03-09
May, 2017 FDA 483 Millers of Wyckoff, Inc. - Form 483, 2017-05-18
February, 2016 FDA 483 Elite Laboratories, Inc. - Form 483, 2016-02-02
June, 2016 FDA 483 Sewaren Innovative Pharmaceutical Packaging dba SIPP - Form 483, 2016-06-28
August, 2017 FDA 483 Novel Laboratories, Inc. - Form 483, 2017-08-08
February, 2017 FDA 483 Givaudan Flavors Corporation - Form 483, 2017-02-08
August, 2017 FDA 483 Response Novel Laboratories, Inc. - Form 483R, 2017-11-30
October, 2017 EIR Integrated Analytical Laboratories, LLC. - EIR, 2017-10-19
January, 2019 FDA 483 Nelson Laboratories Fairfield Inc. - Form 483, 2019-01-07
March, 2018 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2018-03-09
July, 2018 FDA 483 Sharp Drugs, Inc. - Form 483, 2018-07-13
April, 2018 EIR Amneal Complex Products Research LLC - EIR, 2018-04-18
January, 2017 EIR Alvogen, Inc - EIR, 2017-01-18
March, 2016 FDA 483 Forest Research Institute, Inc. - Form 483, 2016-03-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more